Inga Hegemann
- Biochemistry top 5%
- Hematology top 5%
- Hemophilia Treatment and Research 12
- Chronic Myeloid Leukemia Treatments 5
- Iron Metabolism and Disorders 5
- Platelet Disorders and Treatments 4
- Blood Coagulation and Thrombosis Mechanisms 3
- Internal Medicine top 5%
- Health Informatics top 10%
-
- Hemoglobinopathies and Related Disorders 5
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 3
-
- Erythrocyte Function and Pathophysiology 3
- Co-authors
- Gabriela H. SpahnFelix SchoenrathVolkmar FalkDonat R. SpahnBurkhardt SeifertAlexander KasererOliver M. TheusingerPhilipp Stein
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Inga Hegemann
23 papers receiving 495 citations
Peers
Comparison fields: 5 of 57
- Biochemistry 180
- Hematology 241
- Internal Medicine 74
- Critical Care and Intensive Care Medicine 66
- Health Informatics 12
Countries citing papers authored by Inga Hegemann
This map shows the geographic impact of Inga Hegemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inga Hegemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inga Hegemann more than expected).
Fields of papers citing papers by Inga Hegemann
This network shows the impact of papers produced by Inga Hegemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inga Hegemann. The network helps show where Inga Hegemann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Inga Hegemann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 17 | |
| 6 | 2022 | 28 | |
| 7 | 2021 | 18 | |
| 8 | 2021 | 1 | |
| 9 | 2020 | 14 | |
| 10 | 2020 | 69 | |
| 11 | 2020 | 2 | |
| 12 | 2020 | 14 | |
| 13 | 2020 | 16 | |
| 14 | 2019 | 14 | |
| 15 | 2019 | 3 | |
| 16 | 2019 | 221 | |
| 17 | 2018 | 2 | |
| 18 | 2016 | 22 | |
| 19 | 2016 | 16 | |
| 20 | 2010 | 9 |
About Inga Hegemann
Inga Hegemann is a scholar working on Hematology, Genetics and Internal Medicine, having authored 26 papers that have together received 510 indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (12 papers), Chronic Myeloid Leukemia Treatments (5 papers), Iron Metabolism and Disorders (5 papers), Hemoglobinopathies and Related Disorders (5 papers), Platelet Disorders and Treatments (4 papers), Erythrocyte Function and Pathophysiology (3 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). The work is most often cited by research in Biochemistry (180 citations), Hematology (241 citations) and Internal Medicine (74 citations). Inga Hegemann has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Gabriela H. Spahn, Felix Schoenrath, Volkmar Falk, Donat R. Spahn, Burkhardt Seifert, Alexander Kaserer, Oliver M. Theusinger, Philipp Stein, Francesco Maisano and Axel Hofmann. Their work appears in journals such as Swiss Medical Weekly, Blood, Blood Advances, British Journal of Haematology and Journal of Clinical Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.